Voice changes after androgen therapy for hypogonadotrophic hypogonadism

被引:28
作者
Akcam, T
Bolu, E
Merati, AL
Durmus, C
Gerek, M
Ozkaptan, Y
机构
[1] Gulhane Mil Med Acad, Dept Otolaryngol Head & Neck Surg, Ankara, Turkey
[2] Gulhane Mil Med Acad, Dept Endocrinol & Metab, Ankara, Turkey
[3] Med Coll Wisconsin, Dept Otolaryngol & Commun Sci, Div Laryngol, Milwaukee, WI 53226 USA
关键词
hypogonadism; voice; puberty; androgen; larynx;
D O I
10.1097/00005537-200409000-00016
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives/Hypothesis: Males with isolated hypogonadotropic hypogonadism. (IHH) fail to undergo normal sexual development, including the lack of masculinization of the larynx. The objective of this study was to measure the mean vocal fundamental frequency (MF0) in IHH patients and determine the impact of androgen treatment. An additional aim was to compare the MF0 between IHH patients and controls. Study Design: Prospective observational study. Methods: Twenty-four patients with IHH were identified along with 30 normal males and females. Voice recordings were obtained on all subjects. Androgen therapy was administered to the IHH patients. The MF0 and serum sex hormone levels were measured before treatment and at intervals during therapy. These results were compared with the pretreatment data within the IHH group. Voice parameters were also compared between the pre- and posttreatment IHH patients and the normal males and females. Results: The MF0 in untreated IHH patients was 229+/-41 Hz. This was intermediate between the normal male (150+/-22 Hz, P<.001) and normal female patients (256±29 Hz, P<.01). After treatment, the MF0 in the IHH group decreased to 173+/-30 Hz (P<.0001); indeed, their posttreatment MF0 approached that of normal males (P<.08). Serum hormone levels responded to the injected testosterone, but these levels did not directly correlate with MF0. Conclusions. MF0 in IHH patients is intermediate between normal male and female levels. After treatment with testosterone, these values approach the range of normal males. This prospective study details the impact of androgens on the larynx and vocal function in patients with IHH.
引用
收藏
页码:1587 / 1591
页数:5
相关论文
共 15 条
[1]   Sex hormones and the female voice [J].
Abitbol, J ;
Abitbol, P ;
Abitbol, B .
JOURNAL OF VOICE, 1999, 13 (03) :424-446
[2]   A report on alterations to the speaking and singing voices of four women following hormonal therapy with virilizing agents [J].
Baker, J .
JOURNAL OF VOICE, 1999, 13 (04) :496-507
[3]   ANDROGEN STIMULATION AND LARYNGEAL DEVELOPMENT [J].
BECKFORD, NS ;
SCHAID, D ;
ROOD, SR ;
SCHANBACHER, B .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1985, 94 (06) :634-640
[4]   The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men [J].
Bhasin, S ;
Storer, TW ;
Berman, N ;
Callegari, C ;
Clevenger, B ;
Phillips, J ;
Bunnell, TJ ;
Tricker, R ;
Shirazi, A ;
Casaburi, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (01) :1-7
[5]   PERMANENT VOICE CHANGE RESULTING FROM DANAZOL THERAPY [J].
BOOTHROYD, CV ;
LEPRE, F .
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 1990, 30 (03) :275-276
[6]   VOICE CHANGE IN ADULT WOMEN CAUSED BY VIRILIZING AGENTS [J].
DAMSTE, PH .
JOURNAL OF SPEECH AND HEARING DISORDERS, 1967, 32 (02) :126-132
[7]   EFFECT OF TESTOSTERONE ON MUSCLE MASS AND MUSCLE PROTEIN-SYNTHESIS [J].
GRIGGS, RC ;
KINGSTON, W ;
JOZEFOWICZ, RF ;
HERR, BE ;
FORBES, G ;
HALLIDAY, D .
JOURNAL OF APPLIED PHYSIOLOGY, 1989, 66 (01) :498-503
[8]   Changes in the male voice at puberty [J].
Harries, MLL ;
Walker, JM ;
Williams, DM ;
Hawkins, S ;
Hughes, IA .
ARCHIVES OF DISEASE IN CHILDHOOD, 1997, 77 (05) :445-447
[9]   Effects of testosterone replacement on a male professional singer [J].
King, A ;
Ashby, J ;
Nelson, C .
JOURNAL OF VOICE, 2001, 15 (04) :553-557
[10]   FUNDAMENTAL VOICE FREQUENCY MEASURED BY ELECTROGLOTTOGRAPHY DURING CONTINUOUS SPEECH - A NEW EXACT SECONDARY SEX CHARACTERISTIC IN BOYS IN PUBERTY [J].
PEDERSEN, MF ;
MOLLER, S ;
KRABBE, S ;
BENNETT, P .
INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 1986, 11 (01) :21-27